Expression and prognostic roles of β-catenin in hepatocellular carcinoma: Correlation with tumor progression and postoperative survival

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 450-456

  Inagawa, Satoshi ^a   Itabashi, Masayuki ^b   Adachi, Shinya ^a   Kawamoto, Toru ^a   Hori, Masao ^b   Shimazaki, Jiro ^b   Yoshimi, Fuyo ^b   Fukao, Katashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b IBARAKI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; KI 67 ANTIGEN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL ADHESION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

AGED; BETA CATENIN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CYCLIN D1; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TIME FACTORS; TRANS-ACTIVATORS;

EID: 0036190930     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mortality by cause for eight regions of the world: Global burden of disease study
2. Hepatocellular carcinoma. A worldwide problem and the major risk factors
3. Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma
4. Hepatocellolar carcinoma: A comparison of oriental and Caucasian patients
5. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment
6. Prognostic factor after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis
7. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification
8. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
9. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
10. β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
11. Expression of mutant nuclear β-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis
12. β-catenin mutation and overexpression in hepatocellular carcinoma
13. β-catenin accumulation and mutation of exon 3 of the β-catenin gene in hepatocellular carcinoma
14. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation
15. β-catenin mutations are frequent in human hepatocellular carcinoma associated with hepatitis C virus infection
16. Functional interaction of β-catenin with the transcriptional factor LEF-1
17. Wnt signaling and cancer
18. Stabilization of β-catenin by genetic defects in melanoma cell lines
19. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
20. Cadherin-catenin complex: Protein interactions and their implications for cadherin function
21. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
22. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
23. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
24. β-catenin regulates expression of cyclin D1 in colon carcinoma cells
25. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck
26. Amplification and expression of the human cyclin D gene in esophageal cancer
27. Determination of prognostic value of cyclin D1 expression in breast cancer
28. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma
29. Amplification and overexpression of cyclin D1 gene in aggressive human hepatocellular carcinoma
30. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan
31. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC
32. Small hyperechoic nodules in chronic liver disease include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression
33. Mutation of β-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis
34. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody Ki-67
35. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis
36. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinoma
37. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39
38. Hepatomegaly in transgenic mice expressing an oncogenic form of β-catenin
39. β-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity
40. Mutations in the β-catenin gene (CTNNBI) in endometrioid ovarian carcinomas
41. β-catenin mutation in carcinoma of the uterine endometrium